Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality

被引:33
|
作者
Tamburini, Elisa [1 ]
Dallatomasina, Alice [2 ]
Quartararo, Jade [1 ]
Cortelazzi, Barbara [1 ]
Mangieri, Domenica [3 ]
Lazzaretti, Mirca [1 ]
Perris, Roberto [1 ]
机构
[1] Univ Parma, Ctr Mol & Translat Oncol COMT, Parco Area Sci 11-A, I-43124 Parma, Italy
[2] IRCCS, San Raffaele Sci Inst, Div Expt Oncol, Milan, Italy
[3] Univ Foggia, Dept Med Sci, Foggia, Italy
来源
FASEB JOURNAL | 2019年 / 33卷 / 03期
关键词
extracellular matrix; structure-function relationship; macromolecular interactions; signal transduction; CHONDROITIN SULFATE PROTEOGLYCAN; MELANOMA-ASSOCIATED ANTIGEN; CENTRAL-NERVOUS-SYSTEM; HIGH-MOLECULAR-WEIGHT; OLIGODENDROCYTE PRECURSOR CELLS; PDGF ALPHA-RECEPTOR; SPINAL-CORD-INJURY; PROTEIN-KINASE-C; NG2; PROTEOGLYCAN; MONOCLONAL-ANTIBODIES;
D O I
10.1096/fj.201801670R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The chondroitin sulfate proteoglycan 4 (CSPG4) gene encodes a transmembrane proteoglycan (PG) constituting the largest and most structurally complex macromolecule of the human surfaceome. Its transcript shows an extensive evolutionary conservation and, due to the elaborated intracellular processing of the translated protein, it generates an array of glycoforms with the potential to exert variant-specific functions. CSPG4-mediated molecular events are articulated through the interaction with more than 40 putative ligands and the concurrent involvement of the ectodomain and cytoplasmic tail. Alternating inside-out and outside-in signal transductions may thereby be elicited through a tight functional connection of the PG with the cytoskeleton and its regulators. The potential of CSPG4 to influence both types of signaling mechanisms is also asserted by its lateral mobility along the plasma membrane and its intersection with microdomain-restricted internalization and endocytic trafficking. Owing to the multitude of molecular interplays that CSPG4 may engage, and thanks to a differential phosphorylation of its intracellular domain accounted by crosstalking signaling pathways, the PG stands out for its unique capability to affect numerous cellular phenomena, including those purporting pathologic conditions. We discuss here the progresses made in advancing our understanding about the structural-functional bases for the ability of CSPG4 to widely impact on cell behavior, such as to highlight how its multivalency may be exploited to interfere with disease progression.Tamburini, E., Dallatomasina, A., Quartararo, J., Cortelazzi, B., Mangieri, D., Lazzaretti, M., Perris, R. Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality.
引用
收藏
页码:3112 / 3128
页数:17
相关论文
共 50 条
  • [21] Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
    Poli, Aurelie
    Wang, Jian
    Domingues, Olivia
    Planaguma, Jesus
    Yan, Tao
    Rygh, Cecilie Brekke
    Skaftnesmo, Kai Ove
    Thorsen, Frits
    McCormack, Emmet
    Hentges, Francois
    Pedersen, Paal Henning
    Zimmer, Jacques
    Enger, Per Oyvind
    Chekenya, Martha
    ONCOTARGET, 2013, 4 (09) : 1527 - 1546
  • [22] Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma
    Svendsen, Agnete
    Verhoeff, Joost J. C.
    Immervoll, Heike
    Brogger, Jan C.
    Kmiecik, Justyna
    Poli, Aurelie
    Netland, Inger A.
    Prestegarden, Lars
    Planaguma, Jesus
    Torsvik, Anja
    Kjersem, Anneli Bohne
    Sakariassen, Per O.
    Heggdal, Jan I.
    Van Furth, Wouter R.
    Bjerkvig, Rolf
    Lund-Johansen, Morten
    Enger, Per O.
    Felsberg, Joerg
    Brons, Nicolaas H. C.
    Tronstad, Karl J.
    Waha, Andreas
    Chekenya, Martha
    ACTA NEUROPATHOLOGICA, 2011, 122 (04) : 495 - 510
  • [23] Diversified Expression of NG2/CSPG4 Isoforms in Glioblastoma and Human Foetal Brain Identifies Pericyte Subsets
    Girolamo, Francesco
    Dallatomasina, Alice
    Rizzi, Marco
    Errede, Mariella
    Waelchli, Thomas
    Mucignat, Maria Teresa
    Frei, Karl
    Roncali, Luisa
    Perris, Roberto
    Virgintino, Daniela
    PLOS ONE, 2013, 8 (12):
  • [24] CIS-ACTING ELEMENTS OF THE MOUSE CSPG4 (NG2) GENE IN OLIGODENDROCYTE PROGENITOR SPECIFIC TRANSCRIPTION
    Medved, J.
    Nishiyama, A.
    GLIA, 2011, 59 : S54 - S55
  • [25] Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma
    Agnete Svendsen
    Joost J. C. Verhoeff
    Heike Immervoll
    Jan C. Brøgger
    Justyna Kmiecik
    Aurelie Poli
    Inger A. Netland
    Lars Prestegarden
    Jesús Planagumà
    Anja Torsvik
    Anneli Bohne Kjersem
    Per Ø. Sakariassen
    Jan I. Heggdal
    Wouter R. Van Furth
    Rolf Bjerkvig
    Morten Lund-Johansen
    Per Ø. Enger
    Joerg Felsberg
    Nicolaas H. C. Brons
    Karl J. Tronstad
    Andreas Waha
    Martha Chekenya
    Acta Neuropathologica, 2011, 122 : 495 - 510
  • [26] Chondroitin Sulfate Proteoglycan Abnormalities in Schizophrenia: Involvement of NG2 (nerve/glial Antigen 2-CSPG4)
    Berretta, Sabina
    Pantazopoulos, Harry
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S541 - S542
  • [27] Myelin Debris Stimulates NG2/CSPG4 Expression in Bone Marrow-Derived Macrophages in the Injured Spinal Cord
    Liu, Yang
    Hammel, Grace
    Shi, Minjun
    Cheng, Zhijian
    Zivkovic, Sandra
    Wang, Xiaoqi
    Xu, Pingyi
    He, Xijing
    Guo, Bing
    Ren, Yi
    Zuo, Li
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [28] Cryo-EM structure-based small molecule inhibitor drugs targeting CSPG4/NG2 in glioblastoma
    Neset, Lasse
    Nilsen, Mia Kristin
    Arnesen, Victoria Smith
    Alam, Kazi Asraful
    Chekenya, Martha
    Rahman, Mohummad Aminur
    CANCER RESEARCH, 2024, 84 (06)
  • [29] The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas
    Schiffer, Davide
    Mellai, Marta
    Boldorini, Renzo
    Bisogno, Ilaria
    Grifoni, Silvia
    Corona, Cristiano
    Bertero, Luca
    Cassoni, Paola
    Casalone, Cristina
    Annovazzi, Laura
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (09)
  • [30] Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors
    Farnedi, Anna
    Rossi, Silvia
    Bertani, Nicoletta
    Gulli, Mariolina
    Silini, Enrico Maria
    Mucignat, Maria Teresa
    Poli, Tito
    Sesenna, Enrico
    Lanfranco, Davide
    Montebugnoli, Lucio
    Leonardi, Elisa
    Marchetti, Claudio
    Cocchi, Renato
    Ambrosini-Spaltro, Andrea
    Foschini, Maria Pia
    Perris, Roberto
    BMC CANCER, 2015, 15